High Tide Inc
XTSX:HITI

Watchlist Manager
High Tide Inc Logo
High Tide Inc
XTSX:HITI
Watchlist
Price: 3.71 CAD 0.27% Market Closed
Market Cap: 298.5m CAD
Have any thoughts about
High Tide Inc?
Write Note

Relative Value

The Relative Value of one HITI stock under the Base Case scenario is 5.01 CAD. Compared to the current market price of 3.71 CAD, High Tide Inc is Undervalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HITI Relative Value
Base Case
5.01 CAD
Undervaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
34
vs Industry
84
Median 3Y
0.4
Median 5Y
0.5
Industry
2.6
Forward
0.6
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-6.7
Industry
23
Forward
-366.3
vs History
31
vs Industry
44
Median 3Y
7.6
Median 5Y
6.9
Industry
17.8
vs History
15
vs Industry
22
Median 3Y
-6.6
Median 5Y
-6.6
Industry
25.4
vs History
44
vs Industry
46
Median 3Y
1.2
Median 5Y
1.9
Industry
2.2
vs History
42
vs Industry
85
Median 3Y
0.5
Median 5Y
0.5
Industry
2.8
Forward
0.6
vs History
38
vs Industry
73
Median 3Y
1.6
Median 5Y
1.8
Industry
5.4
vs History
52
vs Industry
43
Median 3Y
10.1
Median 5Y
7.8
Industry
13.7
Forward
7.9
vs History
20
vs Industry
16
Median 3Y
-9.1
Median 5Y
-9.1
Industry
17.2
Forward
43.3
vs History
44
vs Industry
43
Median 3Y
8.7
Median 5Y
8.1
Industry
16.5
vs History
23
vs Industry
31
Median 3Y
8.3
Median 5Y
-2.4
Industry
19.3
vs History
25
vs Industry
51
Median 3Y
1
Median 5Y
1.1
Industry
2

Multiples Across Competitors

HITI Competitors Multiples
High Tide Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
High Tide Inc
XTSX:HITI
298.5m CAD 0.6 -9.8 7.4 24.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
777.8B USD 19 92.9 49.9 55.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.2 34.9 24.3 27.7
US
Johnson & Johnson
NYSE:JNJ
367.4B USD 4.2 25 12.1 15.7
US
Merck & Co Inc
NYSE:MRK
249.6B USD 4 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
209.3B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
180.7B CHF 4.2 12.7 10 14.9
UK
AstraZeneca PLC
LSE:AZN
154.9B GBP 4 30.7 169 253.3
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
CA
High Tide Inc
XTSX:HITI
Average P/E: 33.6
Negative Multiple: -9.8
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
92.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
34.9
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.7
21%
UK
AstraZeneca PLC
LSE:AZN
30.7
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top